CYTOKINE REGULATORY AGENTS AND USE IN PATHOLOGIES AND CONDITIONS ASSOCIATED WITH ALTERED CYTOKINE LEVELS

摘要

The present invention relates to novel peptides that are potent cytokine modulators. The invention also relates to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and cytokine modulator. Administration of the cytokine modulator to a subject to be administered may increase or inhibit cytokine activity. Accordingly, the present invention provides a method of modulating cytokine activity in a subject having a disease characterized by abnormalities or alterations in cytokine activity. In addition, the present invention also has adverse side effects caused by, for example, inactivity deconditioning, nitric oxide or cytokine mediated diseases, adverse drug reactions, obesity, sepsis shock, and cancer chemotherapy or as a response to organ transplantation. It provides a method of treating a disease comprising a.